Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Movement Disorders: Official Journal of the Movement Disorder Society
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A Phase 1 Randomized Trial of Specific Active α-Synuclein Immunotherapies PD01A and PD03A in Multiple System Atrophy
Mov. Disord. 2020 Nov 01;35(11)957-1965, WG Meissner, AP Traon, A Foubert-Samier, G Galabova, M Galitzky, A Kutzelnigg, B Laurens, P Lührs, R Medori, P Péran, U Sabatini, S Vergnet, D Volc, W Poewe, A Schneeberger, G Staffler, O Rascol, On Behalf Of The Aff InvestigatorsFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.